Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Inflammatory Bowel Disease I: Introduction

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial protein expression patterns across pathologically-associated fibers revealed molecular specialization in inclusion body myositis.

Cell communication and signaling : CCS·2026

Same author

EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia.

European journal of neurology·2026

Same author

Awareness of bone strength in patients with neuromuscular disorders: ERN EURO-NMD clinician survey and European patient survey.

Journal of the neurological sciences·2025

Same author

Oral ribose supplementation in dystroglycanopathy: A single case study.

JIMD reports·2024

Same author

Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.

Seminars in arthritis and rheumatism·2023

Same author

Perioperative Care for Patients with Neuromuscular Disorders in the Netherlands - A Questionnaire Study Among Anaesthesiologists, Neurologists and Clinical Geneticists.

Journal of neuromuscular diseases·2022

Search research articles

Related Experiment Video

Updated: May 4, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Idiopathic inflammatory myopathies.

A J van der Kooi¹, M de Visser¹

¹Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.

Handbook of Clinical Neurology

|December 25, 2013

Summary

This summary is machine-generated.

Idiopathic inflammatory myopathies (IIMs) are autoimmune diseases causing muscle weakness. While treatable with immunosuppressants, new therapies are needed due to side effects and limited efficacy.

Keywords:

Myositis autoantibodies autoimmune biopsy connective tissue disorder corticosteroids imaging inflammatory myopathy malignancy necrotizing

Related Experiment Videos

Last Updated: May 4, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Area of Science:

Rheumatology
Neurology
Immunology

Background:

Idiopathic inflammatory myopathies (IIMs) are a group of rare autoimmune diseases characterized by muscle weakness and inflammation.
Subclassification includes dermatomyositis (DM), polymyositis (PM), autoimmune necrotizing myopathy, and sporadic inclusion body myositis (sIBM).
These conditions arise from a complex interplay of genetic predisposition and environmental triggers leading to chronic immune activation.

Observation:

IIMs typically present with subacute symmetrical limb-girdle muscle weakness and elevated serum creatine kinase.
Dermatomyositis (DM) is distinguished by associated skin abnormalities.
Autoantibodies are strongly linked to specific clinical presentations and patient prognoses in myositis.

Findings:

Most IIMs, excluding sIBM, respond to immunosuppressive and immunomodulatory treatments.
Prognosis and long-term outcomes for IIMs are variable, with disease-related mortality rates of at least 10% in DM and PM.
Mortality in DM is often linked to malignancy and pulmonary complications, while juvenile DM has a lower mortality rate.

Implications:

Current immunosuppressive therapies for IIMs can cause significant side effects and may not be effective for all patients.
There is a critical need for the development of novel, safe, and effective therapeutic agents for IIMs.
Further research into prognostic factors and long-term outcomes is essential for improving patient management and care.